ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,725Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 32

$1.41M Total Retail Price of All Prescriptions

Rank: 1 out of 32

537 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
85% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 537 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 537 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 27,897 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,210 1,062 S3 1 1
FUROSEMIDE 1,170 1,097 2 5
JANTOVEN 1,145 1,145 10 3 22
LISINOPRIL 959 942 4 3
METOPROLOL TARTRATE 899 885 5 7
RANITIDINE HCL 854 832 6 12
LEVOTHYROXINE SODIUM 835 812 7 4
AMLODIPINE BESYLATE 657 632 8 2
GABAPENTIN 553 521 9 16
DONEPEZIL HCL 489 476 10 30
SERTRALINE HCL 451 415 11 24
NAMENDA 444 432 12 43
CITALOPRAM HBR 411 394 13 27
MIRTAZAPINE 410 399 14 50
OMEPRAZOLE 380 355 15 8
QUETIAPINE FUMARATE 379 363 16 51
LANTUS 379 363 16 29
NOVOLOG 351 320 18 57
METFORMIN HCL 345 322 19 9
POTASSIUM CHLORIDE 327 291 20 14
DIVALPROEX SODIUM 318 293 21 71
HYDROCHLOROTHIAZIDE 304 287 22 11
IPRATROPIUM-ALBUTEROL 301 245 23 85
TAMSULOSIN HCL 290 256 24 34
CYMBALTA 287 251 25 44
ZOLPIDEM TARTRATE 281 255 26 20
RISPERIDONE 279 279 27 39
SIMVASTATIN 275 228 28 6
CARVEDILOL 265 239 29 28
CLOPIDOGREL 256 256 30 38
COUMADIN 251 251 31 70
OLANZAPINE 223 211 32 98
CARBIDOPA-LEVODOPA 219 219 33 84
ESCITALOPRAM OXALATE 213 211 34 89
TRAMADOL HCL 210 197 35 13
FENTANYL 208 165 S2 36 63
HYDROXYZINE HCL 184 169 R 37 110
PLAVIX 181 181 38 64
GLIPIZIDE 175 175 39 40
PHENYTOIN 175 156 10 39 113
LAMOTRIGINE 172 172 41 95
ISOSORBIDE MONONITRATE ER 171 170 42 49
TRAZODONE HCL 171 171 42 53
MONOJECT INSULIN SAFETY SYRNG 166 166 44 115
METOPROLOL SUCCINATE 164 161 45 18
LEVOFLOXACIN 160 148 46 83
SULFAMETHOXAZOLE-TRIMETHOPRIM 159 149 47 41
PREDNISONE 153 137 48 52
PRAVASTATIN SODIUM 152 148 49 10
NEXIUM 151 118 50 23
KLOR-CON 10 149 149 51 97
ALLOPURINOL 148 137 52 26
DIGOXIN 148 143 52 56
DIOVAN 144 131 54 42
KLOR-CON M20 142 142 55 54
PROMETHAZINE HCL 140 106 R 56 59
SEROQUEL 139 139 57 121
BACLOFEN 136 99 58 106
FINASTERIDE 132 131 59 107
ATENOLOL 126 126 60 17
LEVETIRACETAM 125 119 61 74
DILTIAZEM HCL 125 125 61 80
BUDESONIDE 121 82 63 127
LEVEMIR 119 97 64 128
ALBUTEROL SULFATE 115 109 65 129
MELOXICAM 115 115 65 33
PAROXETINE HCL 114 114 67 62
TRIAMCINOLONE ACETONIDE 112 94 68 132
ENALAPRIL MALEATE 109 97 69 95
CLONIDINE HCL 108 87 70 31
AZITHROMYCIN 108 102 70 32
SANTYL 101 100 72 138
DOXYCYCLINE HYCLATE 101 93 72 87
PHENYTOIN SODIUM EXTENDED 100 88 74 102
PANTOPRAZOLE SODIUM 100 97 74 75
METOCLOPRAMIDE HCL 99 82 76 93
EXELON 99 99 76 117
CIPROFLOXACIN HCL 98 89 78 35
AMOX TR-POTASSIUM CLAVULANATE 98 92 78 120
ALENDRONATE SODIUM 97 93 80 82
METFORMIN HCL ER 91 85 81 36
GEMFIBROZIL 91 79 81 116
SINGLE USE SWAB 89 89 83 118
AGGRENOX 89 77 83 145
NOVOLIN R 89 89 83 145
LATANOPROST 88 88 86 147
LACTULOSE 87 81 87 148
KLOR-CON M10 86 86 88 123
CLOTRIMAZOLE-BETAMETHASONE 84 82 89 149
POLYETHYLENE GLYCOL 3350 83 79 90 46
HALOPERIDOL 81 76 91 150
ACTOS 81 81 91 67
ATORVASTATIN CALCIUM 81 81 91 15
LEXAPRO 75 72 94 151
LUMIGAN 71 71 95 153
NOVOLIN N 71 70 95 153
NITROFURANTOIN MONO-MACRO 70 69 97 155
PRAMIPEXOLE DIHYDROCHLORIDE 69 60 98 157
GEODON 68 68 99 158
CLOBETASOL PROPIONATE 67 65 100 161
CEPHALEXIN 67 59 100 48
FLUOXETINE HCL 66 66 102 111
DILTIAZEM ER 61 53 103 165
AMIODARONE HCL 61 60 103 165
GLIPIZIDE ER 61 58 103 118
FLUTICASONE PROPIONATE 60 56 106 58
TOBRAMYCIN-DEXAMETHASONE 60 52 106 167
HUMALOG 60 60 106 129
ROPINIROLE HCL 59 59 109 169
FAMOTIDINE 59 56 109 47
NYSTATIN 59 59 109 169
RIVASTIGMINE 58 58 112 171
LYRICA 56 44 113 68
SPIRONOLACTONE 56 53 113 112
NITROGLYCERIN PATCH 56 56 113 177
KETOCONAZOLE 55 48 116 180
CEFTRIAXONE 54 49 117 185
LOSARTAN POTASSIUM 54 54 117 37
ISOSORBIDE DINITRATE 54 54 117 185
BENZTROPINE MESYLATE 53 53 R 120 126
OXYCODONE-ACETAMINOPHEN 52 50 S2 121 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.